
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PDSS2**: Involved in the biosynthesis of coenzyme Q10, important for mitochondrial function.<br>- **PRKAR2B**: Regulatory subunit of protein kinase A, involved in various signaling pathways.<br>- **IFI27**: Interferon-induced protein, often associated with immune response.<br>- **PIK3R1**: Regulatory subunit of PI3K, involved in cell growth and survival signaling.<br>- **NAMPT**: Nicotinamide phosphoribosyltransferase, involved in NAD biosynthesis and cellular metabolism.<br>- **S100A10**: Part of the S100 protein family, involved in cell cycle progression and differentiation.<br>- **P4HA1**: Prolyl 4-hydroxylase subunit, involved in collagen synthesis.<br>- **KRT7**: Keratin 7, a type II cytokeratin involved in the structural integrity of epithelial cells.<br>- **KRT19**: Keratin 19, another cytokeratin, often used as a marker for epithelial cells.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MUC15**: Mucin 15, associated with epithelial cells and often overexpressed in certain cancers.<br>- **MUCL1**: Mucin-like protein 1, associated with breast tissue.<br>- **CD24**: A cell surface protein often used as a marker for epithelial and cancer stem cells.<br>- **PRLR**: Prolactin receptor, associated with mammary gland development and breast tissue.<br>- **ANKRD30A**: An ankyrin repeat domain-containing protein, associated with breast tissue.<br>- **IGFBP5**: Insulin-like growth factor-binding protein 5, involved in cell growth and survival, often expressed in breast tissue.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:<br>- **KRT7** and **KRT19** are commonly expressed in epithelial cells, particularly in glandular tissues.<br>- **MUC15**, **MUCL1**, and **PRLR** are associated with breast epithelial cells.<br>- **CD24** is a marker for epithelial and cancer stem cells, often used in breast cancer studies.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of epithelial markers such as **KRT7**, **KRT19**, **MUC15**, and **CD24**, the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely breast epithelial cells.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: Characterized by the expression of **KRT7**, **KRT19**, **PRLR**, and **MUCL1**. These cells line the ducts and lobules of the breast and are often involved in breast cancer.<br>2. **Basal/Myoepithelial Cells**: While not as strongly indicated by the markers, these cells are another major component of breast tissue, typically expressing different keratins.<br>3. **Cancer Stem-like Cells**: Indicated by the expression of **CD24** and **ALDH1A1** (not listed but often co-expressed), these cells are involved in tumor initiation and progression.<br><br>The most likely subtype, based on the markers, is **Luminal Epithelial Cells** due to the strong expression of luminal markers like **KRT7**, **KRT19**, and **PRLR**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the expression of key markers such as **KRT7**, **KRT19**, **PRLR**, and **MUCL1**, which are characteristic of luminal epithelial cells in the breast. These cells are significant in the context of breast cancer, as they are often the origin of luminal subtype breast cancers.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency**:<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. For example, markers like **KRT7**, **KRT19**, **MUC15**, **MUCL1**, **CD24**, and **PRLR** are all included in the marker list.<br>   - The identified cell type, luminal epithelial cells, is consistent with the expression of these markers, which are known to be associated with epithelial cells, particularly in breast tissue.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation acknowledges the potential presence of basal/myoepithelial cells and cancer stem-like cells, which is appropriate given the context of breast cancer tissue. However, the markers strongly support the identification of luminal epithelial cells as the predominant cell type.<br>   - There is no strong evidence from the marker list to suggest a significant presence of other distinct cell types that would warrant flagging for mixed cell type consideration.<br><br>Overall, the annotation is well-supported by the marker list and aligns with known biological characteristics of breast epithelial cells, particularly luminal epithelial cells, in the context of breast cancer.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>luminal epithelial cells</li><li>basal/myoepithelial cells</li><li>cancer stem-like cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its relevance to breast cancer tissue. The analysis correctly identifies the main cell type as epithelial cells, with a focus on luminal epithelial cells, which is consistent with the expression of key markers such as KRT7, KRT19, PRLR, and MUCL1. These markers are well-known to be associated with luminal epithelial cells in breast tissue, particularly in the context of breast cancer.<br><br>The annotation also considers the potential presence of basal/myoepithelial cells and cancer stem-like cells, which is appropriate given the complexity of breast cancer tissue. This shows a balanced consideration of multiple markers rather than over-focusing on a specific one. The inclusion of markers like CD24, which is often used as a marker for cancer stem cells, supports this comprehensive view.<br><br>However, there are a few areas where the annotation could be improved. While the analysis acknowledges the potential presence of other cell types, it does not provide a detailed discussion of the markers that might indicate these subtypes. For example, the presence of markers like IFI27 and PIK3R1, which are involved in immune response and cell growth signaling, respectively, could suggest additional cell type considerations that were not fully explored.<br><br>Additionally, the annotation could benefit from a more explicit consideration of the rank of the markers. While the analysis does mention key markers, it does not explicitly address the importance of their position in the ranked list, which could provide further insights into the predominant cell types.<br><br>Overall, the annotation is scientifically accurate and provides a comprehensive view of the cell types present, with a strong focus on luminal epithelial cells. However, there is room for improvement in the consideration of marker rank and the exploration of additional cell types suggested by the marker list.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    